Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,729	1,714	1,839	3,422	3,418
Short-Term Investments	-	-	-	4,929	2,691
Trading Asset Securities	6,656	3,123	4,591	-	-
Cash & Short-Term Investments	9,385	4,837	6,429	8,351	6,109
Cash Growth	94.01%	-24.76%	-23.01%	36.70%	148.94%
Accounts Receivable	5,906	4,504	4,904	2,741	3,262
Other Receivables	29.15	95.15	1.96	12.15	73.23
Receivables	5,935	4,599	4,906	2,753	3,335
Inventory	1,245	3,404	2,113	1,294	582.3
Prepaid Expenses	45.71	2.14	31.67	19.43	25.04
Other Current Assets	1,421	2,039	1,335	814.18	881.44
Total Current Assets	18,031	14,882	14,816	13,232	10,933
Property, Plant & Equipment	10,471	9,981	8,210	6,039	4,759
Long-Term Investments	3,419	1,208	125.53	61.6	36.96
Other Intangible Assets	4.41	38.71	62.43	90.89	68.99
Long-Term Accounts Receivable	31.08	31.12	31.08	31.08	31.12
Long-Term Deferred Tax Assets	273.22	179.47	413.95	249.08	159.38
Other Long-Term Assets	1,990	1,701	249.73	370.15	127.81
Total Assets	34,293	28,076	23,981	20,145	16,189
Accounts Payable	752.17	1,101	1,007	719.41	648.41
Accrued Expenses	606.66	252.29	308.02	249.82	245.63
Short-Term Debt	43.6	429.52	817.96	87.46	274.93
Current Portion of Long-Term Debt	189.74	189.74	390.71	201.3	11.5
Current Portion of Leases	19.73	15.06	16.85	3.22	21.22
Current Income Taxes Payable	373.05	230.27	64.11	58.83	193.89
Current Unearned Revenue	-	-	-	3.85	-
Other Current Liabilities	1,272	1,045	781.21	314.81	866.29
Total Current Liabilities	3,257	3,262	3,386	1,639	2,262
Long-Term Debt	277.34	470.28	1,117	961.88	245.8
Long-Term Leases	8.83	28.56	43.06	7.64	24.39
Long-Term Unearned Revenue	7	9.34	11.69	14.18	16.64
Pension & Post-Retirement Benefits	163.03	43.87	39.78	33.6	31.99
Other Long-Term Liabilities	154.4	162.81	137.21	81.89	57.99
Total Liabilities	3,868	3,977	4,735	2,738	2,639
Common Stock	1,123	1,118	1,118	1,141	87.76
Additional Paid-In Capital	1,512	1,252	1,252	2,719	2,700
Retained Earnings	27,479	21,392	16,879	13,570	10,726
Comprehensive Income & Other	311	336.79	-2.72	-23.05	35.82
Shareholders' Equity	30,425	24,099	19,247	17,407	13,550
Total Liabilities & Equity	34,293	28,076	23,981	20,145	16,189
Total Debt	539.24	1,133	2,385	1,262	577.84
Net Cash (Debt)	8,846	3,704	4,044	7,090	5,531
Net Cash Growth	138.80%	-8.41%	-42.96%	28.17%	286.71%
Net Cash Per Share	15.59	6.60	7.13	12.43	9.70
Filing Date Shares Outstanding	561.71	561.61	559.08	570.49	570.46
Total Common Shares Outstanding	561.71	559.08	559.08	570.49	570.46
Working Capital	14,774	11,619	11,429	11,593	8,671
Book Value Per Share	54.16	43.10	34.43	30.51	23.75
Tangible Book Value	30,421	24,060	19,184	17,316	13,481
Tangible Book Value Per Share	54.16	43.04	34.31	30.35	23.63
Land	836.13	836.13	836.13	836.13	836.13
Buildings	3,432	3,239	2,012	1,579	1,304
Machinery	10,467	8,595	6,761	6,137	4,632
Construction In Progress	2,643	2,969	3,447	1,641	1,538